参考文献/References:
[1] Lim S H,Dubielecka P M,Raghunathan V M.Molecular targeting in acute myeloid leukemia[J].Journal of Translational Medicine,2017,15(1):183.[2] Xu J,Huang B,Liu X,et al.Poor prognosis in acute myeloid leukemia patients with monosomal karyotypes[J].Turk J Haematol,2017,34(2):126-130.[3] Stolzel F,Mohr B,Kramer M,et al.Karyotype complexity and prognosis in acute myeloid leukemia[J].Blood Cancer Journal,2016,6(1):e386.[4] Anelli L,Pasciolla C,Zagaria A,et al.Monosomal karyotype in myeloid neoplasias:a literature review[J].Onco Targets Ther,2017,10:2163-2171.[5] 焦扬.不同染色体核型的初治原发性急性髓系白血病的临床特点分析[J].中华医学遗传学杂志,2018,35(5):727-732.[6] 张之南,沈悌.血液病诊断及疗效标准[M].3版.北京科学出版社,2008:103-115.[7] 刘林,徐欢,陈志妹,等.515例急性髓系白血病患者年龄特异的细胞遗传学分析[J].中华医学遗传学杂志,2019,36(6):552-555.[8] 刘艳春,李伟,王欢,等.染色体核型动态监测对急性白血病患者化疗疗效评估的作用[J].中国实验血液学杂志,2015,23(3):658-662.[9] Xu X Q,Wang J M,Gao L,et al.Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients[J]. American Journal of Hematology,2014,89(9):874-881.[10] McCurdy S R,Levis M J.Emerging molecular predictive and prognostic factors in acute myeloid leukemia[J]. Leuk Lymphoma,2018,59(9): 2021-2039.[11] 赵婷,主鸿鹄,王婧,等.早期评估NPMl突变阳性急性髓系白血病患者残留白血病水平的预后意义[J].中华血液学杂志,2017,38(1):10-16.[12] Haferlach C,Dicker F,Herholz H,et al.Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype[J].Leukemia,2008,22(8):1539-1541.